 |
|
The Changing Face of Hypertension
Is Systolic Blood Pressure the Final Answer?
Arch Intern Med. 2002;162:506-508.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
ALTHOUGH HYPERTENSION has been recognized as a risk factor for cardiovascular
disease (CVD) for more than a century, there has been an ongoing debate regarding
the relative importance of various components of blood pressure (BP) in predicting
the future risk of CVD. Ever since its inception, there has been changing
opinion regarding the importance of diastolic blood pressure (DBP) vs systolic
blood pressure (SBP). With the development of the sphygmomanometer, it became
fanciful for experts to measure DBP. In the early 1900s, it was thought that
higher SBP represented cardiac strength whereas elevated DBP reflected increased
peripheral resistance, the load to which heart and vasculature were exposed
in a constant manner and hence increase in DBP was considered deleterious
to the heart. Furthermore, because DBP measurement was more reproducible,
it was chosen as the primary parameter for diagnosing and staging of hypertension
as well as the main target for therapy . . . [Full Text of this Article]IS SBP THE FINAL ANSWER?
THERAPEUTIC CONSIDERATIONS
FUTURE DIRECTION
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Diastolic Pressure in Type 2 Diabetes: Can target systolic pressure be reached without "diastolic hypotension"?
Osher and Stern
Diabetes Care 2008;31:S249-S254.
ABSTRACT
| FULL TEXT
Adequacy of Glycemic, Lipid, and Blood Pressure Management for Patients With Diabetes in a Managed Care Setting
Beaton et al.
Diabetes Care 2004;27:694-698.
ABSTRACT
| FULL TEXT
Prognostic Value of Systolic and Diastolic Blood Pressure in Treated Hypertensive Men: Clarification
Benetos et al.
Arch Intern Med 2003;163:121-121.
FULL TEXT
Undertreatment of Hypertension: A Dozen Reasons
Gupta et al.
Arch Intern Med 2002;162:2246-2248.
FULL TEXT
|
